3,401–3,450 of 20,598 genesranked by Most Researched
| # | Gene | Name | Chr | Tags | PubMed Papers |
|---|---|---|---|---|---|
| 3401 | CCN4 | cellular communication network factor 4 | 8 | OncogeneExperimental GO Evidence | 136 |
| 3402 | CDC45 | cell division cycle 45 | 22 | Hub GeneOMIM Disease Gene | 136 |
| 3403 | CDC7 | cell division cycle 7 | 1 | Hub GeneKinase | 136 |
| 3404 | CXCL11 | C-X-C motif chemokine ligand 11 | 4 | Hub GeneExperimental GO Evidence | 136 |
| 3405 | DYNC1LI1 | dynein cytoplasmic 1 light intermediate chain 1 | 3 | TransporterExperimental GO Evidence | 136 |
| 3406 | EFNB1 | ephrin B1 | X | Highly ConstrainedOMIM Disease Gene | 136 |
| 3407 | EIF2A | eukaryotic translation initiation factor 2A | 3 | Experimental GO EvidenceSwiss-Prot Reviewed | 136 |
| 3408 | ESRRG | estrogen related receptor gamma | 1 | ReceptorClinical Trials | 136 |
| 3409 | FBLN5 | fibulin 5 | 14 | OMIM Disease GeneExperimental GO Evidence | 136 |
| 3410 | GIPC1 | GIPC PDZ domain containing family member 1 | 19 | OMIM Disease GeneExperimental GO Evidence | 136 |
| 3411 | ID3 | inhibitor of DNA binding 3 | 1 | Experimental GO EvidenceSwiss-Prot Reviewed | 136 |
| 3412 | KDM4A | lysine demethylase 4A | 1 | Highly ConstrainedHub Gene | 136 |
| 3413 | LGALS8 | galectin 8 | 1 | Experimental GO EvidenceSwiss-Prot Reviewed | 136 |
| 3414 | NOP53 | NOP53 ribosome biogenesis factor | 19 | DNA RepairHub Gene | 136 |
| 3415 | SMYD3 | SET and MYND domain containing 3 | 1 | Experimental GO EvidenceSwiss-Prot Reviewed | 136 |
| 3416 | SPTB | spectrin beta, erythrocytic | 14 | Highly ConstrainedOMIM Disease Gene | 136 |
| 3417 | STAM | signal transducing adaptor molecule | 10 | TransporterExperimental GO Evidence | 136 |
| 3418 | TFCP2 | transcription factor CP2 | 12 | Experimental GO EvidenceSwiss-Prot Reviewed | 136 |
| 3419 | TNFRSF4 | TNF receptor superfamily member 4 | 1 | ReceptorClinical Trials | 136 |
| 3420 | WRNIP1 | WRN helicase interacting protein 1 | 6 | DNA RepairExperimental GO Evidence | 136 |
| 3421 | ADAMTS5 | ADAM metallopeptidase with thrombospondin type 1 motif 5 | 21 | ProteaseClinical Trials | 135 |
| 3422 | ALDH1B1 | aldehyde dehydrogenase 1 family member B1 | 9 | Hub GeneExperimental GO Evidence | 135 |
| 3423 | BSCL2 | BSCL2 lipid droplet biogenesis associated, seipin | 11 | OMIM Disease GeneVariant-Rich | 135 |
| 3424 | CHRNB2 | cholinergic receptor nicotinic beta 2 subunit | 1 | Ion ChannelReceptor | 135 |
| 3425 | DPY30 | dpy-30 histone methyltransferase complex regulatory subunit | 2 | Hub GeneExperimental GO Evidence | 135 |
| 3426 | EPS8 | EGFR pathway substrate 8, signaling adaptor | 12 | OMIM Disease GeneExperimental GO Evidence | 135 |
| 3427 | GPR55 | G protein-coupled receptor 55 | 2 | ReceptorExperimental GO Evidence | 135 |
| 3428 | ING1 | inhibitor of growth family member 1 | 13 | Tumor SuppressorOMIM Disease Gene | 135 |
| 3429 | KCNA5 | potassium voltage-gated channel subfamily A member 5 | 12 | Ion ChannelTransporter | 135 |
| 3430 | LAMA2 | laminin subunit alpha 2 | 6 | Hub GeneFDA Approved Target | 135 |
| 3431 | NSFL1C | NSFL1 cofactor | 20 | Experimental GO EvidenceSwiss-Prot Reviewed | 135 |
| 3432 | PTK6 | protein tyrosine kinase 6 | 20 | KinaseFDA Approved Target | 135 |
| 3433 | PTPRA | protein tyrosine phosphatase receptor type A | 20 | Highly ConstrainedExperimental GO Evidence | 135 |
| 3434 | RPE65 | retinoid isomerohydrolase RPE65 | 1 | FDA Approved TargetOMIM Disease Gene | 135 |
| 3435 | SCAMP3 | secretory carrier membrane protein 3 | 1 | TransporterExperimental GO Evidence | 135 |
| 3436 | SLC1A1 | solute carrier family 1 member 1 | 9 | TransporterOMIM Disease Gene | 135 |
| 3437 | SP100 | SP100 nuclear antigen | 2 | Experimental GO EvidenceSwiss-Prot Reviewed | 135 |
| 3438 | SPART | spartin | 13 | TransporterOMIM Disease Gene | 135 |
| 3439 | SYT1 | synaptotagmin 1 | 12 | Highly ConstrainedHub Gene | 135 |
| 3440 | TBX3 | T-box transcription factor 3 | 12 | OMIM Disease GeneExperimental GO Evidence | 135 |
| 3441 | TMEM43 | transmembrane protein 43 | 3 | OMIM Disease GeneExperimental GO Evidence | 135 |
| 3442 | TNFSF14 | TNF superfamily member 14 | 19 | Clinical TrialsExperimental GO Evidence | 135 |
| 3443 | UBD | ubiquitin like modifier D | 6 | Experimental GO EvidenceSwiss-Prot Reviewed | 135 |
| 3444 | WDR26 | WD repeat domain 26 | 1 | Highly ConstrainedOMIM Disease Gene | 135 |
| 3445 | ATP6V1B2 | ATPase H+ transporting V1 subunit B2 | 8 | Hub GeneTransporter | 134 |
| 3446 | CAV2 | caveolin 2 | 7 | Experimental GO EvidenceSwiss-Prot Reviewed | 134 |
| 3447 | CCKBR | cholecystokinin B receptor | 11 | ReceptorFDA Approved Target | 134 |
| 3448 | CD2BP2 | CD2 cytoplasmic tail binding protein 2 | 16 | Experimental GO EvidenceSwiss-Prot Reviewed | 134 |
| 3449 | CIC | capicua transcriptional repressor | 19 | Highly ConstrainedOMIM Disease Gene | 134 |
| 3450 | CLN3 | CLN3 lysosomal/endosomal transmembrane protein, battenin | 16 | TransporterOMIM Disease Gene | 134 |